Targeted therapy reactivates ‘guardian of a genome’ in resistant cancer

It is common for cancer cells to find some approach to lame p53, also famous as “guardian of a genome” due to a movement in preventing poor cells from dividing. “The vicious significance of a protecting duty of p53 is underscored by a farrago of molecular strategies employed by cancer cells to mishandle p53 activity, such as overexpression More...

by Kalen Beh | Published 4 years ago
By Kalen Beh On Saturday, March 14th, 2015
0 Comments

Gene therapy reveals astonishing shield to dystrophin in patients with Duchenne robust dystrophy

An defence greeting to dystrophin, a flesh protein that is poor in patients with Duchenne robust dystrophy, competence poise a new plea to strengthening muscles of patients with this disease, suggests a new investigate More...

By Kalen Beh On Saturday, March 14th, 2015
0 Comments

Breakthrough gene therapy prevents retinal degeneration

In one of usually dual studies of a kind, a investigate from researchers during Tufts University School of Medicine and a Sackler School of Graduate Biomedical Sciences during Tufts demonstrates that non-viral gene More...

By Kalen Beh On Saturday, March 14th, 2015
0 Comments

NIH-funded researchers scold sickle dungeon illness in adult mice

National Institutes of Health-funded scientists have corrected sickle dungeon illness in adult laboratory mice by activating prolongation of a special blood member routinely constructed before, though not after, More...

By Kalen Beh On Saturday, March 14th, 2015
0 Comments

First successful double-blind hearing of gene therapy for modernized Parkinson’s

A multi-center gene therapy hearing for patients with modernized Parkinson’s illness demonstrated reduced symptoms of a on-going transformation disorder, according to a new investigate published in Lancet Neurology. More...

By Kalen Beh On Saturday, March 14th, 2015
0 Comments

Nanodisk gene therapy

One of a hurdles of gene therapy – a set of methodologies directed during treating several nucleic poison diseases (DNA or RNA) – is to assure that this element arrives directly to a iota of a dungeon More...

By Kalen Beh On Saturday, March 14th, 2015
0 Comments

A new genome modifying process brings a probability of gene therapies closer to reality

Researchers from Salk Institute for Biological Studies, BGI, and other institutes for a initial time evaluated a reserve and trustworthiness of a existent targeted gene improvement technologies, and successfully More...

By Kalen Beh On Saturday, March 14th, 2015
0 Comments

New American Chemical Society podcast: Genetically-engineered spider silk for gene therapy

A new part in a American Chemical Society’s (ACS) award-winning “Global Challenges/Chemistry Solutions” podcast array spins a real-life story in that spider silk shows guarantee for overcoming More...

By Kalen Beh On Saturday, March 14th, 2015
0 Comments

Gene therapy shows guarantee as hemophilia diagnosis in animal studies

For a initial time, researchers have total gene therapy and branch dungeon transplantation to successfully retreat a severe, crippling draining commotion hemophilia A in vast animals, opening a doorway to a growth More...

By Kalen Beh On Saturday, March 14th, 2015
0 Comments

Attacking a singular illness during the source with gene therapy

Treating a singular illness MPS we is a challenge. MPS I, caused by a scarcity of a pivotal enzyme called IDUA, eventually leads to a aberrant accumulation of certain molecules and dungeon death. The dual categorical More...